Acquisition of Loan Portfolio

RNS Number : 0486K
Craven House Capital PLC
16 September 2016
 

16th September 2016 

Craven House Capital Plc

("Craven House" or the "Company")

 

Acquisition of Loan Portfolio

 

The Company today announces that it has completed the acquisition of a portfolio of non-performing loans from a major South African bank for a total consideration of ZAR 20,000,000 (twenty million South African Rand).

 

The loans have been acquired a discount to their face value and are secured, in a senior position, against a portfolio of real estate assets in South Africa. The Company is bound by confidentiality requirements to not disclose further details of the transaction at this stage.

 

Mark Pajak, Acting Chairman, commented: "We are very pleased to have negotiated the acquisition of this loan portfolio at a discount to its face value. The underlying assets offer significant security in excess of the face value and the investment is in line with core elements of our strategy; to seek out distressed assets and complicated restructuring opportunities in our target markets. The transaction demonstrates our ability and desire to invest at all levels of the capital structure in order to generate optimal risk adjusted returns.

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

 

For further information please contact:

 

Craven House Capital Plc

Mark Pajak

www.Cravenhousecapital.com

 

  Tel:   020 7002 1027

 

SPARK Advisory Partners Limited

Nominated Adviser

Matt Davis/Mark Brady

www.sparkadvisorypartners.com

Tel:   020 3368 3550

 

 

 

 

 

SI Capital

Broker

Nick Emerson

www.sicapital.co.uk

Tel:   01483 413500

About Craven House Capital

 

Craven House Capital is a frontier and emerging market focused merchant bank seeking value oriented long term investments. Craven House invests in all segments of the capital structure in partnership with local entrepreneurs and the local business community. Craven House provides long term patient capital and is often involved in restructuring, expansion and turn around investments in crisis and transitioning economies.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEAXNKFAKKEEF
UK 100

Latest directors dealings